UniQure's Gene Therapy Shows Promise, CDC Warns of Bacterial Surge, FDA Reviews ENHERTU Cancer Combo, New HIV Prevention Injection, and more...

(0:10): UniQure's Gene Therapy AMT-130 Slows Huntington's Disease by 75%, Boosts Stock 190%(2:00): CDC Warns of 70% Surge in 'Nightmare Bacteria' Infections, Urges Global Action Against Antibiotic Resistance(4:11): FDA Grants Priority Review to ENHERTU Combo for HER2+ Breast Cancer, Promising New Standard of Care(6:02): Revolutionary $40 HIV Prevention Injection to Reach 120 Countries by 2027(7:55): Gore's Climate TRACE Unveils Global Pollution Tracking with Satellite and AI TechnologyTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Tech Space 2.0